Form 4 for RMD ResMed|
Accepted 2022-08-22 00:00:00 ET · period of report 2022-08-18 · accession 0001127602-22-021422 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-22 | 2022-08-18 | RMD | Douglas Robert Andrew | Pres, COO | A - Grant | $0.00 | +4,328 | 21.6K | +25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2022-08-18 | A | A | 4,328 | $0.00 | 21,564 | D | — | — | (F2) Includes 61.1855 shares of ResMed stock purchased on April 29, 2022, through the ResMed Employee Stock Purchase Plan. |